Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on February 14, 2005

Circulation. 2005
Published online before print February 14, 2005, doi: 10.1161/01.CIR.0000155620.10387.43
A more recent version of this article appeared on February 22, 2005
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
111/7/932    most recent
01.CIR.0000155620.10387.43v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reilly, M. P.
Right arrow Articles by Rader, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reilly, M. P.
Right arrow Articles by Rader, D. J.
Related Collections
Right arrow Pathophysiology
Right arrow Risk Factors
Right arrow Imaging
Right arrow Type 2 diabetes
Right arrow CT and MRI

Submitted on November 5, 2004
Accepted on November 15, 2004

Resistin Is an Inflammatory Marker of Atherosclerosis in Humans

Muredach P. Reilly MB*, Michael Lehrke MD, Megan L. Wolfe BS, Anand Rohatgi MD, Mitchell A. Lazar MD, PhD, and Daniel J. Rader MD

From the Divisions of Cardiology (M.P.R., D.J.R.) and Endocrinology, Diabetes, and Metabolism (M.L., M.A.L.), Department of Medicine (M.P.R., M.L., M.L.W., A.R., M.A.L., D.J.R.), Center for Experimental Therapeutics, and the Penn Diabetes Center (M.P.R., M.L.W., D.J.R.), University of Pennsylvania School of Medicine, Philadelphia, Pa.

* To whom correspondence should be addressed. E-mail: muredach{at}spirit.gcrc.upenn.edu.

Background--Resistin, a plasma protein, induces insulin resistance in rodents. Recent reports suggest that circulating levels of resistin are elevated in obese and insulin-resistant rodents and humans. Whereas rodent resistin is made in adipocytes, macrophages are a major source of human resistin. Given the convergence of adipocyte and macrophage function, resistin may provide unique insight into links between obesity, inflammation, and atherosclerosis in humans.

Methods and Results--We examined whether plasma resistin levels were associated with metabolic and inflammatory markers, as well as with coronary artery calcification (CAC), a quantitative index of atherosclerosis, in 879 asymptomatic subjects in the Study of Inherited Risk of Coronary Atherosclerosis. Resistin levels were positively associated with levels of inflammatory markers, including soluble tumor necrosis factor-{alpha} receptor-2 (P<0.001), interleukin-6 (P=0.04), and lipoprotein-associated phospholipase A2 (P=0.002), but not measures of insulin resistance in multivariable analysis. Resistin levels also were associated (odds ratio and 95% confidence interval in ordinal regression) with increasing CAC after adjustment for age, sex, and established risk factors (OR, 1.23 [CI, 1.03 to 1.52], P=0.03) and further control for metabolic syndrome and plasma C-reactive protein (CRP) levels (OR, 1.25 [CI, 1.04 to 1.50], P=0.01). In subjects with metabolic syndrome, resistin levels further predicted CAC, whereas CRP levels did not.

Conclusions--Plasma resistin levels are correlated with markers of inflammation and are predictive of coronary atherosclerosis in humans, independent of CRP. Resistin may represent a novel link between metabolic signals, inflammation, and atherosclerosis. Further studies are needed to define the relationship of resistin to clinical cardiovascular disease.


Key words: resistin • inflammation • diabetes • atherosclerosis




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
C. Jiang, H. Zhang, W. Zhang, W. Kong, Y. Zhu, H. Zhang, Q. Xu, Y. Li, and X. Wang
Homocysteine promotes vascular smooth muscle cell migration by induction of the adipokine resistin
Am J Physiol Cell Physiol, December 1, 2009; 297(6): C1466 - C1476.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. A. Tolpin, C. D. Collard, V.-V. Lee, M. A. Elayda, and W. Pan
Obesity is associated with increased morbidity after coronary artery bypass graft surgery in patients with renal insufficiency
J. Thorac. Cardiovasc. Surg., October 1, 2009; 138(4): 873 - 879.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
C. Chung, A. Long, J. Solus, Y. Rho, A Oeser, P Raggi, and C. Stein
Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis
Lupus, August 1, 2009; 18(9): 799 - 806.
[Abstract] [PDF]


Home page
Eur J EndocrinolHome page
M. Lehrke, A. Becker, M. Greif, R. Stark, R. P Laubender, F. von Ziegler, C. Lebherz, J. Tittus, M. Reiser, C. Becker, et al.
Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis
Eur. J. Endocrinol., August 1, 2009; 161(2): 339 - 344.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Szalowska, M. G. L. Elferink, A. Hoek, G. M. M. Groothuis, and R. J. Vonk
Resistin Is More Abundant in Liver Than Adipose Tissue and Is Not Up-Regulated by Lipopolysaccharide
J. Clin. Endocrinol. Metab., August 1, 2009; 94(8): 3051 - 3057.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. S. Martin, A. N. Qasim, N. N. Mehta, M. Wolfe, K. Terembula, S. Schwartz, N. Iqbal, M. Schutta, R. Bagheri, and M. P. Reilly
Apolipoprotein B but not LDL Cholesterol Is Associated With Coronary Artery Calcification in Type 2 Diabetic Whites
Diabetes, August 1, 2009; 58(8): 1887 - 1892.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
R. Gomez, F. Lago, J. Gomez-Reino, C. Dieguez, and O. Gualillo
Adipokines in the skeleton: influence on cartilage function and joint degenerative diseases
J. Mol. Endocrinol., July 1, 2009; 43(1): 11 - 18.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Butler, A. Kalogeropoulos, V. Georgiopoulou, N. de Rekeneire, N. Rodondi, A. L. Smith, U. Hoffmann, A. Kanaya, A. B. Newman, S. B. Kritchevsky, et al.
Serum Resistin Concentrations and Risk of New Onset Heart Failure in Older Persons: The Health, Aging, and Body Composition (Health ABC) Study
Arterioscler Thromb Vasc Biol, July 1, 2009; 29(7): 1144 - 1149.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D.-E. Lee, S. Kehlenbrink, H. Lee, M. Hawkins, and J. S. Yudkin
Getting the message across: mechanisms of physiological cross talk by adipose tissue
Am J Physiol Endocrinol Metab, June 1, 2009; 296(6): E1210 - E1229.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. R. Collins, C. J. Lyon, X. Xia, J. Z. Liu, R. K. Tangirala, F. Yin, R. Boyadjian, A. Bikineyeva, D. Pratico, D. G. Harrison, et al.
Age-Accelerated Atherosclerosis Correlates With Failure to Upregulate Antioxidant Genes
Circ. Res., March 27, 2009; 104(6): e42 - e54.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. S. Frankel, R. S. Vasan, R. B. D'Agostino Sr, E. J. Benjamin, D. Levy, T. J. Wang, and J. B. Meigs
Resistin, Adiponectin, and Risk of Heart Failure: The Framingham Offspring Study
J. Am. Coll. Cardiol., March 3, 2009; 53(9): 754 - 762.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Ashrafian, C. W. le Roux, A. Darzi, and T. Athanasiou
Effects of Bariatric Surgery on Cardiovascular Function
Circulation, November 11, 2008; 118(20): 2091 - 2102.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. L Fargnoli, T. T Fung, D. M Olenczuk, J. P Chamberland, F. B Hu, and C. S Mantzoros
Adherence to healthy eating patterns is associated with higher circulating total and high-molecular-weight adiponectin and lower resistin concentrations in women from the Nurses' Health Study
Am. J. Clinical Nutrition, November 1, 2008; 88(5): 1213 - 1224.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
Q. Qi, J. Wang, H. Li, Z. Yu, X. Ye, F. B Hu, O. H Franco, A. Pan, Y. Liu, and X. Lin
Associations of resistin with inflammatory and fibrinolytic markers, insulin resistance, and metabolic syndrome in middle-aged and older Chinese
Eur. J. Endocrinol., November 1, 2008; 159(5): 585 - 593.
[Abstract] [Full Text] [PDF]


Home page
ptjournalHome page
L. Stehno-Bittel
Intricacies of Fat
Physical Therapy, November 1, 2008; 88(11): 1265 - 1278.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Cohen, D. Ilic, J. Raupachova, and W. H. Horl
Resistin Inhibits Essential Functions of Polymorphonuclear Leukocytes
J. Immunol., September 15, 2008; 181(6): 3761 - 3768.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. J. Vazquez, C. R. Gonzalez, L. Varela, R. Lage, S. Tovar, S. Sangiao-Alvarellos, L. M. Williams, A. Vidal-Puig, R. Nogueiras, M. Lopez, et al.
Central Resistin Regulates Hypothalamic and Peripheral Lipid Metabolism in a Nutritional-Dependent Fashion
Endocrinology, September 1, 2008; 149(9): 4534 - 4543.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Qasim, N. N. Mehta, M. G. Tadesse, M. L. Wolfe, T. Rhodes, C. Girman, and M. P. Reilly
Adipokines, insulin resistance, and coronary artery calcification.
J. Am. Coll. Cardiol., July 15, 2008; 52(3): 231 - 236.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Weikert, S. Westphal, K. Berger, J. Dierkes, M. Mohlig, J. Spranger, E. B. Rimm, S. N. Willich, H. Boeing, and T. Pischon
Plasma Resistin Levels and Risk of Myocardial Infarction and Ischemic Stroke
J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2647 - 2653.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. S. Ahima and M. A. Lazar
Adipokines and the Peripheral and Neural Control of Energy Balance
Mol. Endocrinol., May 1, 2008; 22(5): 1023 - 1031.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. F. Chehab
Minireview: Obesity and LipOdystrophy--Where Do the Circles Intersect?
Endocrinology, March 1, 2008; 149(3): 925 - 934.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. K. Ohman, Y. Shen, C. I. Obimba, A. P. Wright, M. Warnock, D. A. Lawrence, and D. T. Eitzman
Visceral Adipose Tissue Inflammation Accelerates Atherosclerosis in Apolipoprotein E-Deficient Mice
Circulation, February 12, 2008; 117(6): 798 - 805.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Takata, H. Osawa, M. Kurata, M. Kurokawa, J. Yamauchi, M. Ochi, W. Nishida, T. Okura, J. Higaki, and H. Makino
Hyperresistinemia Is Associated With Coexistence of Hypertension and Type 2 Diabetes
Hypertension, February 1, 2008; 51(2): 534 - 539.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Golledge, P. Clancy, K. Jamrozik, and P. E. Norman
Obesity, Adipokines, and Abdominal Aortic Aneurysm: Health in Men Study
Circulation, November 13, 2007; 116(20): 2275 - 2279.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. A. Ellington, A. R. Malik, G. G. Klee, S. T. Turner, A. D. Rule, T. H. Mosley Jr, and I. J. Kullo
Association of Plasma Resistin With Glomerular Filtration Rate and Albuminuria in Hypertensive Adults
Hypertension, October 1, 2007; 50(4): 708 - 714.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
V. Beauloye, F. Zech, H. Tran Thi Mong, P. Clapuyt, M. Maes, and S. M. Brichard
Determinants of Early Atherosclerosis in Obese Children and Adolescents
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3025 - 3032.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
M. Qatanani and M. A. Lazar
Mechanisms of obesity-associated insulin resistance: many choices on the menu
Genes & Dev., June 15, 2007; 21(12): 1443 - 1455.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. D. Knudson, G. M. Dick, and J. D. Tune
Adipokines and Coronary Vasomotor Dysfunction
Experimental Biology and Medicine, June 1, 2007; 232(6): 727 - 736.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
D. Ribatti, M. T. Conconi, and G. G. Nussdorfer
Nonclassic Endogenous Novel Regulators of Angiogenesis
Pharmacol. Rev., June 1, 2007; 59(2): 185 - 205.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. D. Anderson, N. N. Mehta, M. L. Wolfe, C. C. Hinkle, L. Pruscino, L. L. Comiskey, J. Tabita-Martinez, K. F. Sellers, M. R. Rickels, R. S. Ahima, et al.
Innate Immunity Modulates Adipokines in Humans
J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2272 - 2279.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
H. Osawa, Y. Tabara, R. Kawamoto, J. Ohashi, M. Ochi, H. Onuma, W. Nishida, K. Yamada, J. Nakura, K. Kohara, et al.
Plasma Resistin, Associated With Single Nucleotide Polymorphism -420, Is Correlated With Insulin Resistance, Lower HDL Cholesterol, and High-Sensitivity C-Reactive Protein in the Japanese General Population
Diabetes Care, June 1, 2007; 30(6): 1501 - 1506.
[Abstract] [Full Text] [PDF]


Home page
Epidemiol RevHome page
S. Musaad and E. N. Haynes
Biomarkers of Obesity and Subsequent Cardiovascular Events
Epidemiol. Rev., May 10, 2007; (2007) mxm005v1.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Fantuzzi and T. Mazzone
Adipose Tissue and Atherosclerosis: Exploring the Connection
Arterioscler Thromb Vasc Biol, May 1, 2007; 27(5): 996 - 1003.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
N. P. Kadoglou, D. Perrea, F. Iliadis, N. Angelopoulou, C. Liapis, and M. Alevizos
Exercise Reduces Resistin and Inflammatory Cytokines in Patients With Type 2 Diabetes
Diabetes Care, March 1, 2007; 30(3): 719 - 721.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Bertolani, P. Sancho-Bru, P. Failli, R. Bataller, S. Aleffi, R. DeFranco, B. Mazzinghi, P. Romagnani, S. Milani, P. Gines, et al.
Resistin as an Intrahepatic Cytokine: Overexpression during Chronic Injury and Induction of Proinflammatory Actions in Hepatic Stellate Cells
Am. J. Pathol., December 1, 2006; 169(6): 2042 - 2053.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. M. Dick, P. S. Katz, M. Farias III, M. Morris, J. James, J. D. Knudson, and J. D. Tune
Resistin impairs endothelium-dependent dilation to bradykinin, but not acetylcholine, in the coronary circulation
Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2997 - H3002.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Kremen, M. Dolinkova, J. Krajickova, J. Blaha, K. Anderlova, Z. Lacinova, D. Haluzikova, L. Bosanska, M. Vokurka, S. Svacina, et al.
Increased Subcutaneous and Epicardial Adipose Tissue Production of Proinflammatory Cytokines in Cardiac Surgery Patients: Possible Role in Postoperative Insulin Resistance
J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4620 - 4627.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. Park, S. S. Choe, A H. Choi, K. H. Kim, M. J. Yoon, T. Suganami, Y. Ogawa, and J. B. Kim
Increase in Glucose-6-Phosphate Dehydrogenase in Adipocytes Stimulates Oxidative Stress and Inflammatory Signals
Diabetes, November 1, 2006; 55(11): 2939 - 2949.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Y. Qi, Z. Nie, Y.-S. Lee, N. S. Singhal, P. E. Scherer, M. A. Lazar, and R. S. Ahima
Loss of Resistin Improves Glucose Homeostasis in Leptin Deficiency
Diabetes, November 1, 2006; 55(11): 3083 - 3090.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Ghanim, S. Dhindsa, A. Aljada, A. Chaudhuri, P. Viswanathan, and P. Dandona
Low-Dose Rosiglitazone Exerts an Antiinflammatory Effect with an Increase in Adiponectin Independently of Free Fatty Acid Fall and Insulin Sensitization in Obese Type 2 Diabetics
J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3553 - 3558.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M Otero, R Lago, R Gomez, F Lago, C Dieguez, J J Gomez-Reino, and O Gualillo
Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis
Ann Rheum Dis, September 1, 2006; 65(9): 1198 - 1201.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. J. Bahr, J. Ockenga, K. H. W. Boker, M. P. Manns, and U. J. F. Tietge
Elevated resistin levels in cirrhosis are associated with the proinflammatory state and altered hepatic glucose metabolism but not with insulin resistance
Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E199 - E206.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Kunnari, O. Ukkola, M. Paivansalo, and Y. A. Kesaniemi
High Plasma Resistin Level Is Associated with Enhanced Highly Sensitive C-Reactive Protein and Leukocytes
J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2755 - 2760.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Menzaghi, A. Coco, L. Salvemini, R. Thompson, S. De Cosmo, A. Doria, and V. Trischitta
Heritability of Serum Resistin and Its Genetic Correlation with Insulin Resistance-Related Features in Nondiabetic Caucasians
J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2792 - 2795.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. Nigro, N. Osman, A. M. Dart, and P. J. Little
Insulin Resistance and Atherosclerosis
Endocr. Rev., May 1, 2006; 27(3): 242 - 259.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. Tedgui and Z. Mallat
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Physiol Rev, April 1, 2006; 86(2): 515 - 581.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Mu, R. Ohashi, S. Yan, H. Chai, H. Yang, P. Lin, Q. Yao, and C. Chen
Adipokine resistin promotes in vitro angiogenesis of human endothelial cells
Cardiovasc Res, April 1, 2006; 70(1): 146 - 157.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
S. G. Kim, O. H. Ryu, H. Y. Kim, K. W. Lee, J. A Seo, N. H. Kim, K. M. Choi, J. Lee, S. H. Baik, and D. S. Choi
Effect of rosiglitazone on plasma adiponectin levels and arterial stiffness in subjects with prediabetes or non-diabetic metabolic syndrome.
Eur. J. Endocrinol., March 1, 2006; 154(3): 433 - 440.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. F. Samaha, P. O. Szapary, N. Iqbal, M. M. Williams, L. T. Bloedon, A. Kochar, M. L. Wolfe, and D. J. Rader
Effects of Rosiglitazone on Lipids, Adipokines, and Inflammatory Markers in Nondiabetic Patients With Low High-Density Lipoprotein Cholesterol and Metabolic Syndrome
Arterioscler Thromb Vasc Biol, March 1, 2006; 26(3): 624 - 630.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. S. Burnett, J. M. Devaney, R. J. Adenika, R. Lindsay, and B. V. Howard
Cross-Sectional Associations of Resistin, Coronary Heart Disease, and Insulin Resistance
J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 64 - 68.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. O. Szapary, L. T. Bloedon, F. F. Samaha, D. Duffy, M. L. Wolfe, D. Soffer, M. P. Reilly, J. Chittams, and D. J. Rader
Effects of Pioglitazone on Lipoproteins, Inflammatory Markers, and Adipokines in Nondiabetic Patients with Metabolic Syndrome
Arterioscler Thromb Vasc Biol, January 1, 2006; 26(1): 182 - 188.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Herrmann
Large meals and large arteries: Is resistin the link?
Cardiovasc Res, January 1, 2006; 69(1): 9 - 12.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. S. Jung, K.-H. Park, Y. M. Cho, S. S. Chung, H. J. Cho, S. Y. Cho, S. J. Kim, S. Y. Kim, H. K. Lee, and K. S. Park
Resistin is secreted from macrophages in atheromas and promotes atherosclerosis
Cardiovasc Res, January 1, 2006; 69(1): 76 - 85.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
Z. T. Bloomgarden
2nd International Symposium on Triglycerides and HDL: Metabolic syndrome
Diabetes Care, October 1, 2005; 28(10): 2577 - 2584.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Graveleau, V. G. Zaha, A. Mohajer, R. R. Banerjee, N. Dudley-Rucker, C. M. Steppan, M. W. Rajala, P. E. Scherer, R. S. Ahima, M. A. Lazar, et al.
Mouse and Human Resistins Impair Glucose Transport in Primary Mouse Cardiomyocytes, and Oligomerization Is Required for This Biological Action
J. Biol. Chem., September 9, 2005; 280(36): 31679 - 31685.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Kamin, C. Hadigan, M. Lehrke, S. Mazza, M. A. Lazar, and S. Grinspoon
Resistin Levels in Human Immunodeficiency Virus-Infected Patients with Lipoatrophy Decrease in Response to Rosiglitazone
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3423 - 3426.
[Abstract] [Full Text] [PDF]